Shed signs definitive U.S. commercial agreement with LTR Pharma for ROXUS launch

The deal formalizes an earlier binding term sheet and positions Mavrox as the exclusive U.S. telehealth platform for ROXUS during its initial launch period.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.